Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
[2] There is no UK Summary of Product Characteristics (SmPC) or EMA EPAR, and use is currently limited to clinical trials
EMA and the Heads of Medicines Agencies (HMA), through the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), have issued recommendations to tackle shortages of the glucagon-like peptide-1 (GLP-1) receptor agonists Ozempic (semaglutide), Saxenda (liraglutide), Trulicity (dulaglutide) and Victoza (liraglutide)
It combines expert care, proven medication, and user-friendly tools in a seamless, fully online experience
It delivers a continuous dose of insulin, and it can also give extra doses at mealtimes
US$ 20.37
US$ 25.04
US$ 29.61
